메뉴 건너뛰기




Volumn 133, Issue 6, 2000, Pages 471-473

Assessing the benefits of antiretroviral therapy

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR;

EID: 0034687061     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-6-200009190-00016     Document Type: Editorial
Times cited : (11)

References (20)
  • 15
    • 0008117549 scopus 로고    scopus 로고
    • Guidelines for the use of anti retroviral agents in HIV-infected adults and adolescents Panel on Clinical Practices for Treatment of HIV Infection. Accessed 28 January
    • (2000)
  • 17
    • 3242668469 scopus 로고    scopus 로고
    • Continued low morbidity and mortality among patients with advanced HIV infection and their patterns of highly active antiretroviral therapy usage [Abstract]. The HOPS Investigators
    • Program and Abstracts of the Seventh Conference on Retroviruses and Opportunistic Infections, 30 January-2 February 2000, San Francisco, California. Alexandria, VA: Foundation for Retrovirology and Human Health
    • , vol.2000 , pp. 216
    • Palella, F.1    Moorman, A.2    Chmiel, J.3    Chan, C.4    Holmberg, S.5
  • 20
    • 0003353860 scopus 로고    scopus 로고
    • Delayed immunologic deterioration among patients who virologically fail protease inhibitor-based therapy
    • Program and Abstracts of the Seventh Conference on Retroviruses and Opportunistic Infections, 30 January-2 February 2000, San Francisco, California. Alexandria, VA: Foundation for Retrovirology and Human Health
    • (2000) , pp. 120
    • Deeks, S.G.1    Barbour, J.D.2    Martin, J.N.3    Grant, R.M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.